PROCURE - The Force Against Prostate Cancer

PROCURE in action

News from PROCURE

What is active surveillance for prostate cancer?

Jul 26th, 2017 in News

Active surveillance means monitoring slow-growing prostate cancer instead of undertaking radical treatments such as surgery or radiation right away. The goal is to delay surgery, radiation or other measures for as long as possible in order to avoid the side effects associated with these treatments. Read more

Why do the APS test?

Jul 26th, 2017 in News

The PSA test is often discussed when it comes to screening for prostate cancer. Prostate specific antigen (PSA) is an enzyme produced by the prostate that can be analyzed from a single blood sample. The laboratory test measures nanograms per milliliter of free and bound APS in the blood. Quantities considered normal can vary according to age. Read more

What factors can affect your PSA levels?

Jul 25th, 2017 in News

Prostate specific antigens, usually shortened to the acronym PSA, occur naturally in the prostate. PSAs are present in every man’s bloodstream. However, abnormally high levels of PSA may be a sign of prostate cancer. Read more

PROCURE's conference series

EVERYTHING YOU NEED TO KNOW ABOUT PROSTATE CANCER IN 2017

EVERYTHING YOU NEED TO KNOW ABOUT PROSTATE CANCER IN 2017

To see click here

Read more